DarioHealth Corp., a digital Therapeutics company, announced today the receipt of a license from Health Canada to sell its Dario™ Blood Glucose Monitoring System for Lightning power connector-enabled iPhone smart mobile devices.
“Recognizing the importance of access to the entire iPhone market in Canada, we prioritized this initiative to meet Health Canada’s rigid licensing standards, and our team worked tirelessly to achieve it,” commented Erez Raphael, DarioHealth’s CEO in a statement. “Not only will this access a large segment of new users, but it will allow our existing Canadian users who have upgraded their iPhones to reconnect with our life-enhancing services.”
iPhone users in Canada, including those with prior models that use a headphone jack, as well as those with the Lightning power connector, will now have access to DarioHealth’s digital diabetes products and lifestyle management app features.
Some of the features include glucose level tracking, real-time patient glucose data access for healthcare providers, carb counting, and hypo alerts, amongst others.
DarioHealth has marketed the product in Canada exclusively for Apple iOS 6.1 platform and higher, and for leading Android devices since receiving a license from Health Canada in May 2015.
With this license, DarioHealth’s addressable Canadian market expands to include the entire iPhone user base.